It highlights that rat brains show resilience to the initial tau pathology and that marked cognitive impairments are coincidental with advanced tau pathology and neurodegeneration, a situation resembling the evolution and clinical presentation of AD and other tauopathies. This evidence concerns the gene MAPT and Alzheimer disease.